Differential gut microbiota profiles among normal colorectal mucosa, adenomatous and hyperplastic polyps in healthy volunteers: ColoMAR-1 study.
Abstract
271 Background: Increasing evidence indicates that the interaction between intestinal microbiota and host cells plays an important role in colorectal cancer oncogenesis through immune, inflammatory and/or metabolic alterations. However, there are no clear evidence in the very early adenoma-carcinoma sequence at which microbiota species influences future steps to colorectal carcinoma. This study aims do find a point in the adenoma-carcinoma sequence ad witch microbiota species suggest the risk of a future tumor to develop less invasive forms of early diagnosis. Methods: In this cross-sectional study, healthy volunteers above 45 years old were selected to participate. Exclusion criteria includes previous colonoscopy performed in the last 5 years. Stool sample were collected before a colonoscopy with biopsy. Samples of normal mucosa were systematically obtained, and all polyps found were removed. In fecal samples, microbiota species were identified using GoodGut test: Bacteroides fragilis, Subdoligranulm variabile, Ruminococcus, Roseburia, Coprococcus , eubacteria, Faecalibacterium prausnitzii and Gemella morbillorum . Number of genomic copies/μL were analyzed using the Wilcoxon test. Results: From February to June 2024, 29 healthy volunteers between 45 and 69 years were recruited. 62% were female. Adenomatous polyps or hyperplastic polyps were found in 9 volunteers. No case of colorectal cancer was found. For species S. variabile, Ruminococcus, Roseburia, Coprococcus and F. prausnitzii , higher counts were found in stool samples from volunteers with adenomatous or hyperplastic polyps than in those from volunteer with a normal colonoscopy, both in the total count and after correction for bacterial load (p<0.001). For B. fragilis , bacterial count was higher in samples from volunteers with adenomatous polyps, but not in the samples from people with hyperplastic polyps compared with those samples from volunteers with a normal colonoscopy. G. morbillorum counts were not related to any type of polyps. None of this counts met the laboratory-designated threshold related to colorectal cancer. Conclusions: The presence of B. fragilis could be related to the differential risk of malignancy of adenomatous compared to hyperplastic polyps. Bacterial count for each sample and specie. Bacteria specie* Normal mucosa Adenoma Hyperplastic B. fragilis 22.13 22.3 20.42 S.variable 6.06 7.29 7.53 Ruminococcus, Roseburia, Coprococcus 6.08 7.29 7.47 F. prausnitzii 4.7 6.28 7.09 G.morbillorum 20.91 20.54 20.84 *Number of genomic copies/μL.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (8)
Maria Dolores Martos-Morillo
Hospital Vithas Madrid La Milagrosa, Madrid, Spain
Idoia Sanluis
Hospital Vithas Vigo, Vigo, Spain
Jose M Cardenas
Quantitative and IT Methods Department, San Pablo CEU University, Madrid, Spain
Jose Luis Ulla
Hospital VIthas Vigo, Vigo, Spain
Paula March
Hospital Vithas Aguas Vivas, Valencia, Spain
Jorge Lopez
Hospital Vithas Vigo, Vigo, Spain
Angel Ayuso
Fundación Vithas, Madrid, Spain
Jesus Rodriguez-Pascual
Instituto Oncologico Vithas, Madrid, Spain